Mga Batayang Estadistika
| LEI | 549300M1BOLNXL8DOV14 |
| CIK | 1627223 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to The Chemours Company
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 2, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 29, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 5, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| August 5, 2025 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5. |
|
| August 5, 2025 |
The Chemours Company Reports Second Quarter 2025 Results EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2025 Results Wilmington, Del., August 5, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quar |
|
| August 5, 2025 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| August 5, 2025 |
EXHIBIT 99.2 Q2 2025 Financial Prepared Remarks Comments made in these remarks, as well as in the supplemental information provided on our website, contain forward-looking statements that involve risks and uncertainties as described in The Chemours Company's (the "Company") SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions a |
|
| August 4, 2025 |
Exhibit 10.2 [Execution Version] PFAS INSURANCE PROCEEDS MEMORANDUM OF UNDERSTANDING This binding memorandum of understanding (together with the exhibits hereto, this “MOU”) is made and entered into this 3rd day of August, 2025, by and among The Chemours Company (“Chemours”), Corteva, Inc. (“Corteva”) and DuPont de Nemours, Inc. (f/k/a DowDuPont Inc.) (“DuPont”). “Party” or “Parties” means Chemour |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 4, 2025 (August 3, 2025) Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R. |
|
| August 4, 2025 |
10.1 Form of Judicial Consent Order, dated August 3, 2025 and Exhibit A* Exhibit 10.1 MATTHEW J. PLATKIN ATTORNEY GENERAL OF NEW JERSEY R.J. Hughes Justice Complex 25 Market Street, P.O. Box 093 Trenton, New Jersey 08625-0093 Attorney for Plaintiffs By: Gwen Farley Deputy Attorney General Attorney ID No. 000081999 Ph. (609) 376-2740 [email protected] United States District Court District of New Jersey NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTION; THE COMMI |
|
| August 4, 2025 |
Exhibit 99.1 Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS · Resolves all environmental claims, including those related to PFAS, across four current and former operating sites and all statewide PFAS claims, including those related to aqueous film forming foam (“AFFF”). · Settlement payments over 25 years |
|
| May 29, 2025 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2024 to December 31, 2024 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January |
|
| May 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi |
|
| May 6, 2025 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5. |
|
| May 6, 2025 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| May 6, 2025 |
EXECUTION VERSION EXHIBIT 10.1 AMENDMENT NO. 3 dated as of May 2, 2025 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS and ISSUING BANKS party hereto and JPMORGAN CHASE BANK, N.A. (in its individual capacity, “JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Am |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 6, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incor |
|
| May 6, 2025 |
The Chemours Company Reports First Quarter 2025 Results EXHIBIT 99.1 The Chemours Company Reports First Quarter 2025 Results Wilmington, Del., May 6, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2 |
|
| April 24, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 22, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ De |
|
| April 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def |
|
| April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ De |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def |
|
| March 31, 2025 |
EXHIBIT 99.2 EXECUTION VERSION EXHIBIT A TO THE THIRDFOURTH AMENDMENT, DATED AS OF MARCH 2328, 20232025 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administrative Agent, THE TORONTO-DOMINION BANK, as LC |
|
| March 31, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 31, 2025 |
FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT EXHIBIT 99.1 FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT This FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of March 28, 2025, is among THE CHEMOURS COMPANY AR, LLC, as Seller (in such capacity, the “Seller”), THE CHEMOURS COMPANY FC, LLC (“Chemours”), as initial Servicer (in such capacity, the “Servicer”), RELIANT |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def |
|
| March 20, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 18, 2025 |
NAME OF REGISTRANT: The Chemours Company NAME OF PERSON RELYING ON EXEMPTION: Green Century Capital Management, Inc. |
|
| March 10, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 9, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 13, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 18, 2025 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S. |
|
| February 18, 2025 |
The Chemours Company Reports Fourth Quarter and Full Year 2024 Results EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2024 Results Wilmington, Del., February 18, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results fo |
|
| February 18, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 18, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 18, 2025 |
EXHIBIT 10.16 AMENDMENT NO. 2 dated as of December 13, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18 |
|
| February 18, 2025 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| February 18, 2025 |
EXHIBIT 10.15 AMENDMENT NO. 1 dated as of November 29, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18 |
|
| February 18, 2025 |
EXHIBIT 19 The Chemours Company Insider Trading Policy 1. Background The Chemours Company (“Chemours,” or the “Company”) and its directors, officers and employees worldwide must act in a manner that does not misuse material financial or other information that has not been publicly disclosed. Failure to do so impacts our integrity. Also in some jurisdictions, including the United States, insider tr |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified |
|
| February 18, 2025 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5. |
|
| February 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 10, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 11, 2025 |
EXHIBIT 99.1 Chemours Appoints Leslie M. Turner to its Board of Directors Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours’ Board of Directors Wilmington, Del., February 11, 2025 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologi |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 3, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I |
|
| January 7, 2025 |
EXHIBIT 99.1 Chemours Appoints Google Executive Joseph Kava to its Board of Directors Board addition brings strong tech industry expertise to advance the company’s Pathway to Thrive business strategy Wilmington, Del., January 7, 2025 – The Chemours Company (Chemours) (NYSE: CC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to |
|
| December 13, 2024 |
The Chemours Company Announces Completion of Euro denominated Term Loan Repricing EXHIBIT 99.1 The Chemours Company Announces Completion of Euro denominated Term Loan Repricing Wilmington, Del., December 13, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the successful repricing of its Tranche B-3 Euro denominated Term Loan under its senior secured term loan facility due in August 2028. The Second Amendment reduces the applicable margin in respect of the Comp |
|
| December 13, 2024 |
EXHIBIT 10.1 AMENDMENT NO. 2 dated as of December 13, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18, |
|
| December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| December 2, 2024 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| December 2, 2024 |
EXHIBIT 4.1 THIRD SUPPLEMENTAL INDENTURE Dated as of November 27, 2024 among THE CHEMOURS COMPANY, as Issuer, THE SUBSIDIARY GUARANTORS PARTY HERETO, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee, to the Indenture, dated as of November 27, 2020, relating to Senior Debt Securities EXHIBIT 4.1 Table of Contents Page ARTICLE 1 DEFINITIONS 1 SECTION 1.1 Definition of Terms. 1 SECTION 1.2 Limite |
|
| November 29, 2024 |
The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing EXHIBIT 99.1 The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing Wilmington, Del., November 29, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028. The repricing reduces the applicable margin in respect of t |
|
| November 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 29, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 29, 2024 |
EXHIBIT 10.1 AMENDMENT NO. 1 dated as of November 29, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18, |
|
| November 27, 2024 |
EXHIBIT 99.1 The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033 Wilmington, Del., November 27, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $600,000,000 in aggregate principal amount of 8.000% senior unsecured notes due 2033 |
|
| November 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 27, 2024 | ||
| November 13, 2024 |
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033 EXHIBIT 99.1 The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033 Wilmington, Del., November 13, 2024 – The Chemours Company (Chemours) (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of Ch |
|
| November 13, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 13, 2024 |
EXHIBIT 99.2 The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033 WILMINGTON, Del., November 13, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the “Notes”). The Notes will bear interest at |
|
| November 4, 2024 |
The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy EXHIBIT 99.1 The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy Wilmington, Del., November 4, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), tod |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S |
|
| November 4, 2024 |
Third Quarter 2024 Earnings Presentation November 4, 2024 Exhibit 99.2 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events ba |
|
| November 4, 2024 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| November 4, 2024 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| November 4, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 4, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| August 14, 2024 |
The Chemours Company Investor Presentation August 2024 The Chemours Company Investor Presentation August 2024 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 14, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I |
|
| August 1, 2024 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| August 1, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 1, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| August 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif |
|
| August 1, 2024 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| August 1, 2024 |
The Chemours Company Reports Second Quarter 2024 Results EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2024 Results Wilmington, Del., August 1, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 23, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 12, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| June 13, 2024 |
Chemours Names Tony Satterthwaite to Board of Directors EXHIBIT 99.1 Chemours Names Tony Satterthwaite to Board of Directors Wilmington, Del., June 13, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston “Tony” Satterthwaite to its Board of Directors, effec |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| June 5, 2024 |
Chemours Appoints Shane Hostetter as Chief Financial Officer EXHIBIT 99.1 Chemours Appoints Shane Hostetter as Chief Financial Officer Wilmington, Del., June 5, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective J |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| June 3, 2024 |
EXHIBIT 99.1 The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought Wilmington, Del., May 31, 2024 – As a result of the severe drought impacting much of Mexico, The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, today announced it is complying with a request from the government to temporarily minimize water i |
|
| May 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi |
|
| May 30, 2024 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2023 to December 31, 2023 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January |
|
| May 23, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 21, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 30, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 30, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| April 30, 2024 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci |
|
| April 30, 2024 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| April 30, 2024 |
The Chemours Company Reports First Quarter 2024 Results EXHIBIT 99.1 The Chemours Company Reports First Quarter 2024 Results Wilmington, Del., April 30, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarte |
|
| April 25, 2024 |
Exhibit 10.1 EXECUTION COPY SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”), dated as of April 23, 2024, is by and between The Chemours Company (the “Company”), and Jonathan S. Lock (“Executive”). The Company and Executive are hereinafter referred to as the “Parties”. WHEREAS, Executive has been employed by the Company as its Senior Vice President and Chie |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 23, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 11, 2024 |
2024 NOTICE OF ANNUAL SHAREHOLDERS MEETING AND PROXY STATEMENT1007MarketStreet Wilmington,Delaware19801 April 11, 2024 Dear Fellow Shareholders: Thank you for your continued investment in Chemours. |
|
| April 11, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| April 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| March 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 29, 2024 |
Exhibit 99.1 Transcript – The Chemours Company, Q4 2023 Earnings Call, Mar 28, 2024 Ú Call Participants EXECUTIVES Brandon Ontjes Vice President of FP&A and Investor Relations Denise M. Dignam President & CEO Matthew S. Abbott Interim CFO and Principal Financial & Accounting Officer ANALYSTS Arun Shankar Viswanathan RBC Capital Markets, Research Division Hassan Ijaz Ahmed Alembic Global Advisors J |
|
| March 28, 2024 |
EXHIBIT 99.1 Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review Discloses Material Weaknesses and Remediation Plan Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), |
|
| March 28, 2024 |
The Chemours Company Reports Fourth Quarter and Full Year 2023 Results EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for t |
|
| March 28, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 28, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 27, 2024 |
Incentive-Based Compensation Clawback Policy for Executive Officers. EXHIBIT 97 The Chemours Company Incentive-Based Compensation Clawback Policy for Executive Officers (Effective on October 25, 2023) This Policy covers each current and former “Executive Officer,” within the meaning of Rule 10D-1 adopted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 303A. |
|
| March 27, 2024 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| March 27, 2024 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified |
|
| March 27, 2024 |
EXHIBIT 10.41 AMENDMENT TO SPECIAL EMPLOYMENT AND SEPARATION AGREEMENT AND RELEASE This Amendment to the Special Employment and Separation Agreement and Release (“Amendment”), is dated as of December 19, 2023 (the “Effective Date”), and is made by and between THE CHEMOURS COMPANY (“Chemours” or “Employer” or “Company”), and DAVID C. SHELTON (“Shelton” or “Employee”). Chemours and Shelton are somet |
|
| March 27, 2024 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Chemicals Rus Russia Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S. |
|
| March 27, 2024 |
EXHIBIT 10.43 AGREEMENT AND RELEASE This Special Employment and Separation Agreement and Release ("Release" or “Agreement”) is made and entered into this 25th day of September 2023 by and between and The Chemours Company (“Chemours” or "Employer" or “Company”) and Susan Kelliher ("Employee"), in connection with Employee's change of role effective October 1, 2023 (the “Effective Date”) and separati |
|
| March 26, 2024 |
Exhibit 99.1 Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call Wilmington, Del., March 26, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ende |
|
| March 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 26, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 25, 2024 |
EX-10.1 Exhibit 10.1 EXECUTION COPY SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”), dated as of March 22, 2024, is by and between The Chemours Company (the “Company”), and Mark E. Newman (“Executive”). The Company and Executive are hereinafter referred to as the “Parties”. WHEREAS, Executive has been employed by the Company as its President and Chief Exec |
|
| March 25, 2024 |
EX-99.1 Exhibit 99.1 Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company Wilmington, Del., March 22, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Denise |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 19, 2024 |
Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing Exhibit 99.1 Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing Wilmington, Del., March 18, 2024 – On March 18, 2024, The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 18, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission File |
|
| March 7, 2024 |
Chemours Provides update on Internal Review Exhibit 99.1 Chemours Provides update on Internal Review Wilmington, Del., March 6, 2024 (Business Wire) – As previously disclosed, the Audit Committee of the Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), with the assistance of independent outside counsel, has been overseeing an internal review. The review relates to an anonymous report made to the Chemours E |
|
| March 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 6, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission File |
|
| February 29, 2024 |
Commission File Number: 001-36794 CUSIP Number: 163851108 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 28, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission F |
|
| February 29, 2024 |
EX-99.1 Exhibit 99.1 February 28, 2024 WILMINGTON, Del.–(BUSINESS WIRE) – The Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer). Ms. Dignam joined Chemours in 2015 and has served as our President – T |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 29, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission F |
|
| February 16, 2024 |
EXHIBIT 99.1 Chemours Announces Changes to its Board of Directors Pamela Fletcher appointed as director; Sandra Phillips Rogers will not stand for reelection Wilmington, Del., February 16, 2024 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today an |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 12, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 12, 2024 (November 17, 2023) Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commissi |
|
| February 13, 2024 |
Chemours Reschedules Earnings Release and Conference Call EXHIBIT 99.1 Chemours Reschedules Earnings Release and Conference Call Wilmington, Del., February 13, 2024 – The Chemours Company (“Chemours”or “the Company") (NYSE: CC) today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023, which had previously been scheduled for February 14, 2024 and Febr |
|
| February 13, 2024 |
CC / The Chemours Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0590-chemourscothe.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Chemours Co/The Title of Class of Securities: Common Stock CUSIP Number: 163851108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the r |
|
| February 13, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| January 8, 2024 |
January 8, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street N. |
|
| December 22, 2023 |
December 22, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street N. |
|
| November 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 28, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 29, 2023 |
EXHIBIT 99.1 Chemours Announces Settlement Agreement with State of Ohio Agreement resolves the State's multiple PFAS-related claims. Wilmington, Del., November 29, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces that it, along |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 17, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 22, 2023 |
EXHIBIT 99.1 The Chemours Company Announces Changes to its Board of Directors Curtis Crawford retires from Board, Alister Cowan appointed director Wilmington, Del., November 22, 2023 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces two |
|
| October 27, 2023 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S |
|
| October 27, 2023 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| October 26, 2023 |
EXHIBIT 99.1 The Chemours Company Announces Third Quarter 2023 Results Continued actions through the Titanium Technologies Transformation Plan to drive improved margins FY 2023 Adjusted EBITDA guidance lowered 8% at the midpoint Wilmington, Del., October 26, 2023 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Te |
|
| October 26, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| August 23, 2023 |
EXHIBIT 10.1 EXECUTION VERSION AMENDMENT AND RESTATEMENT AGREEMENT dated as of August 18, 2023 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS and ISSUING BANKS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”) under the Amended and |
|
| August 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 18, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I |
|
| August 1, 2023 |
EXHIBIT 99.1 Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million Wilmington, Del., August 1, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it completed the sale of |
|
| August 1, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 31, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| July 28, 2023 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| July 28, 2023 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| July 28, 2023 |
EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan Solid second quarter despite signs of demand weakness, FY 2023 Adjusted EBITDA guidance lowered 9% at the midpoint Wilmington, Del., July 27, 2023 - The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| July 26, 2023 |
EXHIBIT 99.1 Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions New Leader Poised to Continue Delivering Strong Performance Wilmington, Del., July 26, 2023 – The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced th |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| June 30, 2023 |
EXHIBIT 10.1E EXHIBIT E: NOTICE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-02873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) NOTICE OF PROPOSED CLASS ACTION SETTLEMENT AND COURT APPROVAL HEARING TO: All Public Water Systems in the United States of America that draw or otherwise collect from any Water Source that |
|
| June 30, 2023 |
Exhibit A – Proposed Preliminary Approval Order EXHIBIT 10.1A Exhibit A: [Proposed] Order GRANTING PRELIMINARY APPROVAL UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) [PROPOSED] ORDER GRANTING PRELIMINARY APPROVAL OF Settlement AGREEMENT Before the Court is the Motion of proposed Class Counsel for Preliminary Appro |
|
| June 30, 2023 |
EXHIBIT 10.1F EXHIBIT F: SUMMARY NOTICE NOTICE OF PROPOSED CLASS ACTION SETTLEMENT AND COURT-APPROVAL HEARING In re: Aqueous Film-Forming Foams Product Liability Litigation, MDL No. 2:18-mn-02873 This Document relates to: City of Camden, et al., v. E.I. DuPont de Nemours and Company, et al., No. 2:23-cv-XXXX-RMG United States District Court, District of South Carolina, Charleston Division TO THE S |
|
| June 30, 2023 |
EXHIBIT 10.1 EXECUTION COPY UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) CLASS ACTION Settlement Agreement This Settlement Agreement (including its Exhibits) is entered into, subject to Preliminary and Final Approval of the Court, as of June 30, 2023 (the “Settlemen |
|
| June 30, 2023 |
EXHIBIT 10.1H EXHIBIT H: ESCROW AGREEMENT CUSTODIAN/ESCROW AGREEMENT This Custodian/Escrow Agreement dated [●], 2023, is made among (i) The Chemours Company, The Chemours Company FC, LLC, DuPont de Nemours, Inc., Corteva, Inc., and E.I. DuPont de Nemours and Company n/k/a EIDP, Inc. (each a “Settling Defendant” and collectively, the “Settling Defendants”), (ii) Michael A. London and the law firm o |
|
| June 30, 2023 |
Exhibit B – Proposed Final Approval Order EXHIBIT 10.1B Exhibit B: [Proposed] ORDER GRANTING FINAL APPROVAL UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) [PROPOSED] FINAL ORDER AND JUDGMENT APPROVING SETTLEMENT AGREEMENT Before the Court is the Motion of Class Counsel for Final Approval of Settlement Agreeme |
|
| June 30, 2023 |
Exhibit J – Excluded Federal-Owned Public Water Systems EXHIBIT 10.1J EXHIBIT J: EXCLUDED FEDERAL-OWNED PUBLIC WATER SYSTEMS PWS ID PWS Name Type Owner AK2211423 JBER-ELMENDORF Community Water System Federal Government AK2370625 EIELSON - AIR FORCE BASE Community Water System Federal Government AK2372245 EIELSON - BIRCH LAKE RECREATION AREA Transient Non-Community Water System Federal Government AK2390594 DENALI - MAIN / FRONT COUNTRY Non-Transient Non |
|
| June 30, 2023 |
Exhibit C – Allocation Procedures EXHIBIT 10.1C EXHIBIT C: ALLOCATION PROCEDURES This Document describes the Allocation Procedures referred to in Section 11.5 of the Settlement Agreement. All capitalized terms not otherwise defined herein shall have the meanings set forth in the Settlement Agreement (which are included in the Definitions Annex attached hereto). The Court will appoint a Special Master and Claims Administrator pursu |
|
| June 30, 2023 |
EXHIBIT 10.1D EXHIBIT D: CLAIMS FORMS Aqueous Film-Forming Foam (AFFF) Products Liability Litigation (MDL 2873) Public Water System Settlement Claims Form INSTRUCTIONS Please follow the instructions below to submit a claim for the AFFF Products Liability Litigation Settlement Program. A completed copy of this Claims Form must be submitted no later than the Claims Form Deadline. Late Claims Forms w |
|
| June 30, 2023 |
EXHIBIT 10.1G EXHIBIT G: NOTICE PLAN As detailed below, the Notice Plan provides for individual direct notice via USPS mail to all reasonably identifiable Settlement Class Members, outreach to national and local water organizations, a comprehensive media plan, and the implementation of a dedicated Settlement website and toll-free telephone line where Settlement Class Members can learn more about t |
|
| June 30, 2023 |
Exhibit L – Stipulation of Partial Dismissal With Prejudice EXHIBIT 10.1L EXHIBIT L: STIPULATION OF PARTIAL DISMISSAL [CAPTION OF MDL MEMBER CASE OR OTHER LITIGATION] STIPULATION OF DISMISSAL OF RELEASED CLAIMS WITH PREJUDICE PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 41(a)(1)(A)(ii) Pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedure, Plaintiff in the above-captioned action and Defendants The Chemours Company, The Chemours Company FC |
|
| June 30, 2023 |
Exhibit I – Excluded State-Owned Public Water Systems EXHIBIT 10.1I EXHIBIT I: EXCLUDED STATE-OWNED PUBLIC WATER SYSTEMS PWS ID PWS Name Type Owner AR0000315 ADC - CUMMINS UNIT MAINT Community Water System State Government AS9711948 Central ASG Community Water System State Government AZ0407555 ASPC LEWIS COMPLEX WATER SYSTEM Community Water System State Government AZ0411705 ADOC EYMAN UNIT Community Water System State Government AZ0414099 ASPC YUMA C |
|
| June 30, 2023 |
Exhibit K – Authorization Letter EXHIBIT 10.1K EXHIBIT K: AUTHORIZATION LETTER [Letterhead of Settlement Class Member] [Date] [Claims Administrator], as Claims Administrator [Address] [Address] To the Claims Administrator: Reference is made to Paragraph 11.6.2 of the Class Action Settlement Agreement, dated as of June 30, 2023, by and among (i) Class Representatives, individually and on behalf of the Settlement Class Members, by |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| June 6, 2023 |
EXHIBIT 99.1 Sameer Ralhan Resigns as Chemours Chief Financial Officer (CFO); Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer Wilmington, Del., June 6, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solut |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| June 2, 2023 |
Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems EXHIBIT 99.1 Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems WILMINGTON, Del., June 2, 2023 – The Chemours Company (NYSE: CC), DuPont de Nemours, Inc. (NYSE: DD) and Corteva, Inc. (NYSE: CTVA) (the “companies”) today announced they have reached an agreement in principle to comprehensively resolve all PFAS-related drinking water claims of a defined class of |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| June 1, 2023 |
EXHIBIT 99.1 The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million WILMINGTON, Del., NASHVILLE, Tn, June 1, 2023 - The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered int |
|
| May 31, 2023 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. EX-1.01 2 cc-ex101.htm EX-1.01 Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2022 to December 31, 2022 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for th |
|
| May 31, 2023 |
SD 1 cc-2023conflictmineral.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 12, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco |
|
| May 18, 2023 |
EXHIBIT 99.1 Chemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader WILMINGTON, Del.- MAY 18, 2023 (BUSINESS WIRE)- The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technolog |
|
| April 28, 2023 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci |
|
| April 28, 2023 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| April 27, 2023 |
EXHIBIT 99.1 The Chemours Company Reports First Quarter 2023 Results Strong first quarter in Thermal & Specialized Solutions, company reaffirming full year 2023 Adjusted EBITDA and Free Cash Flow guidance Wilmington, Del., April 27, 2023 - The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (TT), Thermal & Specialized Solu |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 29, 2023 |
THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT EXHIBIT 99.1 EXECUTION VERSION THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT This THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of March 23, 2023, is among THE CHEMOURS COMPANY AR, LLC, as Seller (in such capacity, the “Seller”), THE CHEMOURS COMPANY FC, LLC (“Chemours”), as initial Servicer (in such capacity, the “Serv |
|
| March 29, 2023 |
EXHIBIT 99.2 EXECUTION VERSION EXHIBIT A TO THE SECONDTHIRD AMENDMENT, DATED AS OF NOVEMBER 24MARCH 23, 20212023 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administrative Agent, THE TORONTO-DOMINION BAN |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 23, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 23, 2023 |
EXHIBIT 99.1 Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials Business strategies are unchanged as the company promotes top executives Wilmington, Del., March 23, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 16, 2023 |
EXHIBIT 99.1 Chemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader WILMINGTON, Del., March 16, 2023 - The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Te |
|
| March 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 15, 2023 |
EXHIBIT 10.1 [EXECUTION VERSION] AMENDMENT NO. 2 dated as of March 10, 2023 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), and JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”), to the Amended and Restated Credit Agreement dated as of April 3, 2018 (as amended, supplemented or otherwise modified from time to |
|
| March 10, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def |
|
| February 14, 2023 |
CC / Chemours Co / Sessa Capital (Master), L.P. Passive Investment SC 13G/A 1 fp0082117-2sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 3)* THE CHEMOURS COMPANY (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 163851108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| February 10, 2023 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Chemicals Rus Russia Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S. |
|
| February 10, 2023 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| February 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified |
|
| February 10, 2023 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2022, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| February 9, 2023 |
EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook Delivered record annual results in TSS and APM driven by strong secular tailwinds Wilmington, Del., February 9, 2023 - The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, an |
|
| February 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 9, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 9, 2023 |
CC / Chemours Co / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Chemours Co. Title of Class of Securities: Common Stock CUSIP Number: 163851108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| December 27, 2022 |
Bradley J. Bell December 21, 2022 Dawn Farrell, Chair of the Board Mark Newman, Chief Executive Officer Chemours Corporation Dear Dawn and Mark: At the end of our last Compensation and Leadership Development Committee (CLDC) meeting, management shared a brief update on changes that had been made to employee benefits at Chemours, and those to become effective in 2023. Included in that roster was th |
|
| December 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 21, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission |
|
| December 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 21, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| November 28, 2022 |
Chemours 3Q 2022 Investor Presentation November 2022 Chemours 3Q 2022 Investor Presentation November 2022 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. |
|
| November 28, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 28, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| October 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S |
|
| October 26, 2022 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| October 26, 2022 |
EXHIBIT 4.1 Execution Version INSTRUMENT OF RESIGNATION, APPOINTMENT AND ACCEPTANCE (the “Agreement”) entered into as of the 1st day of August 2022 among The Chemours Company, a Delaware corporation (the “Issuer”), U.S. Bank National Association ("the Retiring Trustee"), and Deutsche Bank Trust Company Americas, a New York banking corporation (“DBTCA"’). W I T N E S S E T H WHEREAS, the Issuer and |
|
| October 26, 2022 |
List of Guarantor Subsidiaries Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2022, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4. |
|
| October 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 25, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| October 25, 2022 |
EXHIBIT 99.1 The Chemours Company Reports Third Quarter 2022 Results Continued strength in APM and TSS despite uncertain macroeconomic conditions Wilmington, Del., October 25, 2022 - The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced its |
|
| October 25, 2022 |
EXHIBIT 99.2 Q3 2022 Earnings Prepared Comments Jonathan Lock, The Chemours Company, Senior Vice President, Chief Development Officer Welcome to The Chemours Company?s Third Quarter 2022 earnings conference call. I'm joined today by Mark Newman, President and Chief Executive Officer, and Sameer Ralhan, Senior Vice President and Chief Financial Officer. Before we start, I?d like to remind you that |
|
| September 21, 2022 |
The Chemours Company Provides Update on Full Year 2022 Guidance EXHIBIT 99.1 The Chemours Company Provides Update on Full Year 2022 Guidance Wilmington, Del., September 21, 2022 - The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today provided an update on full year 2022 guidance. Adjusted EBITDA for 2022 is now e |
|
| September 21, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 21, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer O |
|
| August 22, 2022 |
EXHIBIT 10.1 AGREEMENT AND RELEASE This Special Employment and Separation Agreement and Release ("Release" or ?Agreement?) is made and entered into this 19 day of August 2022 by and between and The Chemours Company (?Chemours? or "Employer" or ?Company?) and David C. Shelton ("Employee"), in connection with Employee's change of role effective October 1, 2022 (the ?Effective Date?) and separation o |
|
| August 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 19, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I |
|
| August 22, 2022 |
EXHIBIT 99.1 The Chemours Company Announces Promotion of Kristine Wellman to Senior Vice President, General Counsel & Corporate Secretary, as Dave Shelton Announces Retirement and Moves to Role as Special Counsel to the CEO Wilmington, Del., August 22, 2022 ? The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & S |
|
| August 1, 2022 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2022, the following subsidiaries of The Chemours Company (the ?Company?) were guarantors of the Company?s 4. |
|
| August 1, 2022 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif |
|
| July 28, 2022 |
EXHIBIT 99.1 The Chemours Company Reports Robust Second Quarter 2022 Results Strong demand drives record TSS and APM performance, now targeting the high end of Adjusted EBITDA guidance range and increasing Free Cash Flow outlook Wilmington, Del., July 28, 2022 - The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 28, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| July 28, 2022 |
EXHIBIT 99.2 Q2 2022 Earnings Prepared Comments Jonathan Lock, The Chemours Company, Senior Vice President, Chief Development Officer Welcome to The Chemours Company?s Second Quarter 2022 earnings conference call. I'm joined today by Mark Newman, President and Chief Executive Officer, and Sameer Ralhan, Senior Vice President and Chief Financial Officer. Before we start, I?d like to remind you that |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi |
|
| May 24, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2021 to December 31, 2021 This Conflict Minerals Report (the ?Report?) of The Chemours Company (?Chemours,? or the ?Company?) has been prepared pursuant to Rule 13p-1 and Form SD (the ?Rule?) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January |
|
| May 3, 2022 |
EX-95 7 cc-ex958.htm EX-95 Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. The following table provides information about citations, orders and notices issued from the Mine Safety an |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci |
|
| May 3, 2022 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2022, the following subsidiaries of The Chemours Company (the ?Company?) were guarantors of the Company?s 4. |
|
| May 2, 2022 |
EXHIBIT 99.1 The Chemours Company Reports Robust First Quarter 2022 Results TSS and APM lead strong overall business performance, FY 2022 Adjusted EBITDA guidance raised 12% at the midpoint Wilmington, Del., May 2, 2022 - The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Per |
|
| May 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 2, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incor |
|
| April 29, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In |
|
| March 11, 2022 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant ?Filed by a Party other than the Registrant ? ? ? Check the appropriate box: ? ? ? ? ? ? ? ? Preliminary Proxy Statement ? ? ? ? ? ? ? ? Confidential, for Use of the Commiss |
|
| March 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ??) Filed by the Registrant ?Filed by a Party other than the Registrant ? ? ? Check the appropriate box: ? ? ? ? ? ? ? ? Preliminary Proxy Statement ? ? ? ? ? ? ? ? Confidential, for Use of the Commission Only (as permi |
|
| March 3, 2022 |
March 2022 Investor Presentation. Chemours 1Q 2022 Investor Materials March 2022 EXHIBIT 99.1 Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on ce |
|
| March 3, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 2, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc |
|
| February 14, 2022 |
CC / Chemours Co / Sessa Capital (Master), L.P. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2)* THE CHEMOURS COMPANY (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 163851108 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 14, 2022 |
SCHEDULE 13G CUSIP No. 163851108 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of March 23, 2020, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified |
|
| February 11, 2022 |
Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia. |
|
| February 11, 2022 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada ChemFirst Inc. |
|
| February 11, 2022 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2021, the following subsidiaries of The Chemours Company (the ?Company?) were guarantors of the Company?s 4. |
|
| February 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 10, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 10, 2022 |
CC / Chemours Co / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Chemours Co. Title of Class of Securities: Common Stock CUSIP Number: 163851108 Date of Event Which Requires Filing of this Statement: January 31, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 13 |
|
| February 10, 2022 |
EXHIBIT 99.1 The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook Broad strength despite logistics and pandemic related headwinds ? full year 2022 outlook targets continued earnings growth and strong free cash flow generation Wilmington, Del., February 10, 2022 - The Chemours Company (?Chemours?) (NYSE: CC), a global chemistry company |
|
| February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 8, 2022 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| February 9, 2022 |
CC / Chemours Co / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Chemours Co. Title of Class of Securities: Common Stock CUSIP Number: 163851108 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| December 1, 2021 |
Chemours Completes Sale of Mining Solutions Business to Draslovka for $521 Million EXHIBIT 99.1 Chemours Completes Sale of Mining Solutions Business to Draslovka for $521 Million WILMINGTON, Del., December 1, 2021 /PRNewswire/ ? The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced it completed the sal |
|
| December 1, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 1, 2021 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| December 1, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 24, 2021 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of |
|
| December 1, 2021 |
SECOND AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT EXHIBIT 99.1 EXECUTION VERSION SECOND AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT This SECOND AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this ?Amendment?), dated as of November 24, 2021, is among THE CHEMOURS COMPANY AR, LLC, as Seller (in such capacity, the ?Seller?), THE CHEMOURS COMPANY FC, LLC (?Chemours?), as initial Servicer (in such capacity, the |
|
| December 1, 2021 |
Amendments to the Amended and Restated Receivables Purchase Agreement (Attached) EXHIBIT 99.2 Exhibit A Amendments to the Amended and Restated Receivables Purchase Agreement (Attached) Exhibit A 743411429 19618061 EXHIBIT 99.2 EXECUTION VERSION EXHIBIT A TO THE FIRST SECOND AMENDMENT, DATED AS OF March 5, NOVEMBER 24, 2021 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO |
|
| November 5, 2021 |
List of Guarantor Subsidiaries. Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2021, the following subsidiaries of The Chemours Company (the ?Company?) were guarantors of the Company?s 4. |
